Nutech Cancer Biomarkers India Private Limited
Founded in 2017 and headquartered in Maharashtra, India.
2017 | Mumbai, Maharashtra (India) | Active
Nutech Cancer Biomarkers India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 33.43%
- Ebitda 33.43%
- Net Worth -22.38%
- Total Assets -19.82%
About Nutech Cancer Biomarkers India
Nutech Cancer Biomarkers India Private Limited (NCBIPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 December 2017 (Seven years and four months 17 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Tushar Barad, Uddhav Kelavkar, and Kalpana Kelavkar serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85100MH2017PTC302616
- Company No.
302616
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Dec 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Healthcare
Nutech Cancer Biomarkers India Private Limited
Explore comprehensive data for Nutech Cancer Biomarkers India Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Nutech Cancer Biomarkers India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tushar Barad  | Director | 08-Dec-2017 | Current |
Kalpana Kelavkar  | Director | 08-Dec-2017 | Current |
| Uddhav Kelavkar | Director | 08-Dec-2017 | Current |
Financial Performance of Nutech Cancer Biomarkers India.
Nutech Cancer Biomarkers India Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 33.43% increase in profit. The company's net worth observed a substantial decline by a decrease of 22.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nutech Cancer Biomarkers India?
Unlock access to Nutech Cancer Biomarkers India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Applied Bioscience India Private LimitedTushar Barad is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nutech Cancer Biomarkers India?
Unlock and access historical data on people associated with Nutech Cancer Biomarkers India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nutech Cancer Biomarkers India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nutech Cancer Biomarkers India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Nutech Cancer Biomarkers India
Recent activity within the organization
- Annual General Meeting
Nutech Cancer Biomarkers India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Nutech Cancer Biomarkers India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
- Director Appointment
Tushar Kumar Kantilal Barad was appointed as a Director was appointed as a Director on 08 Dec 2017 & has been associated with this company since 7 years 4 months .
- Director Appointment
Uddhav Prabhakar Kelavkar was appointed as a Director was appointed as a Director on 08 Dec 2017 & has been associated with this company since 7 years 4 months .
- Director Appointment
Kalpana Patel Kelavkar was appointed as a Director was appointed as a Director on 08 Dec 2017 & has been associated with this company since 7 years 4 months .
- Company Incorporation
Nutech Cancer Biomarkers India Private Limited was registered on 08 Dec 2017 with Roc Mumbai & aged 7 years 4 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Nutech Cancer Biomarkers India Private Limited?
Nutech Cancer Biomarkers India Private Limited was incorporated on 08 Dec 2017.
What is authorized share capital and paid-up capital of Nutech Cancer Biomarkers India Private Limited?
The authorized share capital of Nutech Cancer Biomarkers India Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Nutech Cancer Biomarkers India Private Limited?
Currently 3 directors are associated with Nutech Cancer Biomarkers India Private Limited.
- Tushar Kumar Kantilal Barad
- Uddhav Prabhakar Kelavkar
- Kalpana Patel Kelavkar
What is the registered address of Nutech Cancer Biomarkers India Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Nutech Cancer Biomarkers India Private Limited is Office No 4 Green Medows Complex Akurli Road Lokhandwala Circle, Kandivali East India, Mumbai, Maharashtra, 400101.
What is the corporate identification number (CIN) and company number of Nutech Cancer Biomarkers India Private Limited?
The corporate identification number (CIN) of Nutech Cancer Biomarkers India Private Limited is U85100MH2017PTC302616 and the company number is 302616 as per Ministry of Corporate Affairs (MCA).
What change has been observed in the net worth of Nutech Cancer Biomarkers India Private Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Nutech Cancer Biomarkers India Private Limited has experienced an downturn of -22.38%.
When was the last Balance Sheet of Nutech Cancer Biomarkers India Private Limited filed with the ROC?
The most recent Balance Sheet for Nutech Cancer Biomarkers India Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records